Prostate Cancer Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
Zolenic - Injection
Used to treat hypercalcemia caused by malignant tumor or bone metastasis of multiple myeloma and solid cancer or prostate ...
CONTACT SUPPLIER -
Manufacturerbased in Franklin, TENNESSEE (USA)
Created by urologists for urologists, UroTech is the best way to use advanced medical technology: Avoid significant capital expenditures: Purchasing just one of the advanced technologies now available - much less the five offered by UroTech - would ...
Prostate Cancer Treatments for Protate Cancer
A variety of treatment options are available, according to the stage of the prostate cancer. Physicians and patients are advised to thoroughly explore all options before deciding on a treatment. The Treatment ...
CONTACT SUPPLIER -
Manufacturerbased in Vaulx-en-Velin, FRANCE
Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes minimally-invasive medical devices for urology using ultrasound technology. EDAP TMS ...
EDAP TMS - Model Focal One - Focal HIFU for Prostate Cancer (PCa)
Focal treatment strategy for Prostate Cancer (PCa) is playing a growing role in today's surgical practice. By combining the latest imaging and treatment technologies, Focal One® brings the answer to current ...
CONTACT SUPPLIER -
Manufacturerbased in Irvine, CALIFORNIA (USA)
MDxHealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on ...
SelectMDx - Actionable Molecular Diagnostic System for Prostate Cancer
SelectMDx Helps Physicians Determine if a Patient is at Higher or Lower Risk for Prostate Cancer and Which Men Can Safely Avoid Biopsy. A non-invasive urine test (“liquid biopsy”), SelectMDx measures ...
CONTACT SUPPLIER -
Manufacturerbased in Woodinville, WASHINGTON (USA)
Cancer Targeted Technology is designing and patenting small molecular weight enzyme inhibitors with unique and exceptional imaging and drug delivery properties. Cancer Targeted Technology (CTT) develops innovative targeted agents for cancer that ...
Model CTT1057 - 18F-Labeled PET Agent for Prostate Cancer
CTT1057 is an innovative 18F-labeled PET agent for prostate cancer that can be imaged within 2 hours of administration. CTT1057 will specifically and sensitively detect cancer that has escaped from ...
CONTACT SUPPLIER -
Service providerbased in San Diego, CALIFORNIA (USA)
Decipher, a part of Veracyte, offers genomic tests for urologic cancers. Decipher Biosciences offers a portfolio of genomic tests, continues to build the GRID database of over 70,000 whole transcriptome profiles, and is partnering with ...
Prostate Cancer Treatment
Using Decipher genomic testing to determine where a patient is within the spectrum of risk empowers you in personalizing patient ...
CONTACT SUPPLIER -
Manufacturerbased in Arnhem, NETHERLANDS
Soteria Medical B.V. is a Spin Off from Radboudumc in Nijmegen, The Netherlands. Many years of development and clinical research have resulted in a new approach to perform MRI guided interventions by utilizing a robotic device, which is fully ...
Prostate Cancer Treatment
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. ...
CONTACT SUPPLIER -
Manufacturerbased in Solna, SWEDEN
Vivesto AB is a specialty pharmaceutical company focused on thedevelopment of new therapeutic options for patients suffering from hard-to-treatcancers. It has an emerging pipeline of clinical-stage assets targeting late-stagecancers. Apealea® ...
Docetaxel Micellar
the first clinical study on the treatment of metastasized prostate cancer with Vivesto’s Docetaxel micellar formulation. In June 2021 the first patient was dosed in an investigator-initiated Phase 1b clinical ...
CONTACT SUPPLIER -
Manufacturerbased in Saint-Prex, SWITZERLAND
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty ...
Firmagon - Advanced Hormone-Dependent Prostate Cancer
FIRMAGON® (degarelix) is a treatment for men with advanced hormone-dependent prostate cancer. It has a novel mechanism of action that is different from traditional LHRH agonist therapy commonly used. Decreasing ...
CONTACT SUPPLIER -
Technologybased in Melbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
Starpharma - Prostate Cancer Drug Cabazitaxel
DEP® cabazitaxel is an enhanced version of leading prostate cancer drug cabazitaxel (Jevtana®). Cabazitaxel (Jevtana®) had global sales of €536M in 2020 despite having multiple US FDA “Black ...
CONTACT SUPPLIER -
Software vendorbased in Cambridge, MASSACHUSETTS (USA)
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning artificial intelligence software for translating images into discoveries, decisions, and diagnoses. The cloud based Aiforia products and services ...
Aiforia - Clinical AI Model for Prostate Cancer, Gleason Grade Groups
Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor areas. Automatically scores a quantitative Gleason grade score and grade group from WSI, saving the pathologist ...
CONTACT SUPPLIER -
Manufacturerbased in Petah Tikva, ISRAEL
Isotopia Molecular Imaging was established in 2007 by renowned Israeli scientists and experts in the field of radio pharmaceuticals, and in collaboration with the International Metronotario investment organization. Advancing cancer diagnosis and ...
isoPROtrace - Model 11 - Prostate-Specific Membrane Antigen (PSMA) Kit
Prostate cancer is one of the leading causes of morbidity and mortality in men in the western world, and the second most common cancer in men worldwide. Imaging of the ...
CONTACT SUPPLIER -
Manufacturerbased in Miserey, FRANCE
Innovative Solutions for Cancer Diagnostics. OncoDiag is a French biotechnology company based in Normandy at one hour from Paris and Rouen cities. The company is focused on developing of non-invasive diagnostic tests for early detection of cancers. ...
Prostadiag - Accurate Tissue-Based Test Kit for Prostate Cancer
An accurate tissue-based test to predict non-evolutive localized prostate cancer (LPCa). ...
CONTACT SUPPLIER -
Manufacturerbased in Toronto, ONTARIO (CANADA)
Focal Healthcare is a world-class medical device company dedicated to improving the physician and patient experience from prostate cancer diagnosis to treatment. Throughout his career, Chicuong realized that there were many inefficiencies, ...
Fusion - Model Bx - Semi-Robotic Arm System
Prostate cancer is the only solid cancer still diagnosed through random sampling. Get accurate and meaningful results faster with a targeted approach. Thoughtfully engineered, the semi-robotic arm ...
CONTACT SUPPLIER -
Manufacturerbased in Edmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
ClarityDX Prostate - Prostate Cancer Blood Test Kit
Our lead product, ClarityDx Prostate® is designed to be a highly accurate test to assist in diagnosing clinically significant prostate cancer and improve prostate healthcare ...
CONTACT SUPPLIER -
Technologybased in Woburn, MASSACHUSETTS (USA)
We are leading the way in developing green, enabling biotechnology and nanotechnology drug delivery platforms and enhanced therapeutic products for health maintenance, disease prevention and the treatment of certain cancers, infectious diseases and ...
Aphios - Model APH-0701 - Prostate Cancer Prevalence and Demographics
Prostate cancer is the most prevalent cancer among men, and it is the second leading cause of cancer death among men in the United States. More than 500,000 cases are diagnosed ...
CONTACT SUPPLIER -
Software vendorbased in San Diego, CALIFORNIA (USA)
Cortechs.ai is the leader in radiology AI applications, using cutting-edge advances in medical imaging to revolutionize disease screening and early detection so patients can enjoy longer, better lives. The company develops and markets breakthrough ...
OnQ Prostate - Breakthrough Software Supporting Improved Prostate Cancer Detection
OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction ...
CONTACT SUPPLIER -
Manufacturerbased in Sunnyvale, CALIFORNIA (USA)
Olympia Diagnostics is an In Vitro Diagnostics (IVD) company focusing on development and commercialization of the most advanced breakthrough products for cancer diagnosis and prognosis. We developed a proprietary biomarker discovery platform to ...
Olympia - Model PCa-Tx - Diagnostic Test Kit
A diagnostic test kit quantitatively measures the expression levels of a panel of prostate cancer risk-associated biomarkers in patient urine sample or biopsy tissue sample to distinguish high-risk and aggressive ...
CONTACT SUPPLIER -
Manufacturerbased in Golden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
Vitro - Human Prostate Cancer Associated Fibroblasts: 1,000,000 Cells Per Vial
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen (1% - 5% O2). ...
CONTACT SUPPLIER -
Manufacturerbased in Aurora, COLORADO (USA)
Triopsy Medical, Inc. manufacturer of Cancer Diagnosis system. Our new Triopsy approach will create opportunity across three key market segments: medical device, pathology systems, and mapping systems for more accurate diagnosis. Our novel biopsy ...
Multi-Aspect Device
. Reimbursement codes already exist for our planned products with a related reimbursement strategy already in place, and there is value for all stakeholders – patients, physicians, hospitals, and payers. The company was founded by ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you